Skip to main content

Day: February 12, 2021

Daily Journal Corporation Announces Financial Results for the Three Months ended December 31, 2020

      LOS ANGELES, Feb. 12, 2021 (GLOBE NEWSWIRE) — During the three months ended December 31, 2020, Daily Journal Corporation (NASDAQ:DJCO) had consolidated revenues of $10,420,000 as compared with $11,677,000 in the prior year period.  This decrease of $1,257,000 was primarily from (i) Journal Technologies’ decreased license and maintenance fees of $177,000, consulting fees of $445,000 and public service fees of $32,000, and (ii) reductions in the Traditional Business’ display advertising net revenues of $164,000, classified advertising net revenues of $65,000, trustee sale notice advertising net revenues of $102,000, legal notice advertising net revenues of $53,000, government notice advertising net revenues of $50,000 and circulation revenues of $109,000. The Traditional Business’ pretax income increased by $275,000 to $527,000...

Continue reading

Namaste Technologies Announces Receipt of Health Canada Processing Licence by CannMart Labs

TORONTO, Feb. 12, 2021 (GLOBE NEWSWIRE) — Namaste Technologies Inc. (“Namaste” or the “Company”) (TSXV: N) (FRANKFURT: M5BQ) (OTCMKTS: NXTTF) a marketplace platform for cannabis and wellness products, is pleased to announce that its wholly owned subsidiary CannMart Labs Inc. (“CannMart Labs”) has received a standard processing licence from Health Canada (the “Standard Processing Licence”). The Company will now focus on the next step in the process, which is commissioning the equipment, a process which will commence immediately. The Company will leverage its existing sales licence through CannMart Inc. to bring our recreational products to provinces in Canada where Namaste already has a distribution network in place. We expect to have CannMart Labs manufactured products in the market by the end of Q2 2021.Highlights of CannMart Labs:CannMart...

Continue reading

PRESS RELEASE: BIGBEN INTERACTIVE (ISIN FR0000074072) announces the success of the placement of €87,3 million senior conditionally secured bonds exchangeable into shares of NACON

PRESS RELEASELesquin, February 12th  2021NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH, OR TO PERSONS IN ANY JURISDICTION TO WHOM, SUCH DISTRIBUTION WOULD BE UNLAWFUL.This press release is for information purposes only and does not constitute an offer to sell or a solicitation of an offer to buy any securities and the offer of Nacon shares in the concurrent accelerated bookbuilding and of the offer of the exchangeable bonds by Bigben Interactive does not constitute a public offering other than to qualified investors in any jurisdiction, including in France.BIGBEN INTERACTIVE (ISIN FR0000074072) announces the success of the placement of€87,3 million senior conditionally secured bonds exchangeable into shares of NACONBigben...

Continue reading

Mereo BioPharma Group plc Announces Closing of Public Offering of American Depositary Shares and Full Exercise of Underwriters’ Option to Purchase Additional American Depositary Shares

LONDON and REDWOOD CITY, Calif., Feb. 12, 2021 (GLOBE NEWSWIRE) — Mereo BioPharma Group plc (NASDAQ: MREO) (“Mereo” or the “Company”), a clinical-stage biopharmaceutical company focused on oncology and rare diseases, announced the closing of its previously announced underwritten public offering of 39,675,000 American Depositary Shares (“ADSs”), at a public offering price of $2.90 per ADS, which includes 5,175,000 additional ADSs issued upon the exercise in full of the underwriters’ option to purchase additional ADSs. Each ADS represents five ordinary shares of Mereo. The aggregate gross proceeds to Mereo from the offering, before deducting underwriting discounts and commissions and offering expenses were $115.1 million. All of the ADSs in the offering were sold by Mereo.SVB Leerink acted as sole book-running manager for the offering....

Continue reading

Radius Health, Inc. Provides Abaloparatide Business Update

17% growth in January 2021 for new TYMLOS® patients vs. previous 4 month trailing averageHistomorphometry study published: Journal of Bone & Mineral Research in January 2021Cardiovascular safety study published: Journal of Clinical Endocrinology & Metabolism in November 2020Japan: with our partner – Teijin – the regulatory timelines remain on scheduleCanada: with our recently announced partner – Paladin Labs – regulatory activity on scheduleAbaloparatide wearABLe study (Transdermal System) and the ATOM study (Osteoporotic Men at High Risk of Fracture) remain on scheduleBOSTON, Feb. 12, 2021 (GLOBE NEWSWIRE) — Radius Health, Inc. (“Radius” or the “Company”) (Nasdaq: RDUS) provided a business update on the abaloparatide global business. Progress was made, and continues to be made, across the following areas.New Patient Growth:...

Continue reading

Årsregnskabsmeddelelse 2020 – PRÆCISERING

Selskabsmeddelelse nr. 3/2021København, 12. februar 2021Gyldendal A/SVed selskabsmeddelelse nr. 2/2021 i går kl. 10.13 udsendte sin Gyldendal sin årsrapport via Nasdaq’s systemer. Årsrapporten i PDF-udgave var vedhæftet selskabsmeddelelsen.I går kl. 18 blev årsrapporten i ESEF-udgave (European Single Electronic Format) indberettet til Finanstilsynet via Finanstilsynets OAM-system.Det præciseres hermed, at indholdet af de to indberettede årsrapporter i hhv. PDF-udgave og EFES-udgave er 100% identisk, men at det er årsrapporten i ESEF-udgaven, der udgør den autentiske version af Gyldendals årsrapport i henhold til transparensreglerne.For god ordens skyld vedhæftes den autentiske version af årsrapporten i EFES-format denne meddelelse.For yderligere oplysninger:Direktør Bjarne PonikowskiTelefon 3375 5708Mobil 2529 2282Vedhæftet filgyldenda...

Continue reading

COMMUNIQUE DE PRESSE: BIGBEN INTERACTIVE (ISIN FR0000074072) annonce le succès du placement de 87,3 millions d’euros d’obligations senior conditionnellement garanties échangeables en actions de la société NACON

BigbenCOMMUNIQUE DE PRESSELesquin, 12 février 2021DIFFUSION, PUBLICATION OU DISTRIBUTION INTERDITE, DIRECTEMENT OU INDIRECTEMENT, AUX ETATS-UNIS, EN AUSTRALIE, AU CANADA OU AU JAPON OU DANS TOUTE AUTRE JURIDICTION DANS LAQUELLE, OU À DES PERSONNES DANS TOUTE JURIDICTION DANS LAQUELLE, UNE TELLE DISTRIBUTION SERAIT ILLÉGALELe présent communiqué de presse est à titre informatif uniquement et ne constitue pas une offre de vente ou une sollicitation d’une offre d’achat de titres et l’offre d’actions Nacon dans le cadre du placement accéléré concomitant et l’offre d’obligations échangeables par Bigben Interactive ne constituent pas une offre au public à des personnes autres que des investisseurs qualifiés dans une quelconque juridiction, y compris en France.BIGBEN INTERACTIVE (ISIN FR0000074072) annonce le succès...

Continue reading

Pinnacle Bankshares Corporation Announces Fourth Quarter and 2020 Earnings

ALTAVISTA, Va., Feb. 12, 2021 (GLOBE NEWSWIRE) — Net income for Pinnacle Bankshares Corporation (OTCQX:PPBN), the one-bank holding company (“Pinnacle” or the “Company”) for First National Bank (“First National” or the “Bank”), was $1,805,000, or $0.92 per basic and diluted share, for the quarter ended December 31, 2020, and $3,380,000, or $2.04 per basic and $2.036 per diluted share, for the year ended December 31, 2020.   Net income was $684,000, or $0.44 per basic and diluted share, and $4,396,000, or $2.84 per basic share and $2.82 per diluted share, respectively, for the same periods of 2019.   Consolidated results for the fourth quarters of 2020 and 2019 and the full year 2020 are unaudited.Profitability as measured by the Company’s return on average assets (“ROA”) decreased to 0.58% for the year ended December 31, 2020, as...

Continue reading

Endelige udbytter 2020 for Værdipapirfonden Sparindex

ID-Sparinvest, Filial af Sparinvest S.A., Luxembourg offentliggør endelige a conto udbytter for 2020 for afdelinger i Værdipapirfonden Sparindex.Udbytterne udbetales til investorernes konti torsdag den 25. februar 2021, jf. fondsbørsmeddelelse den 13. januar 2021.Den sidste handelsdag med investeringsbeviser inkl. udbytter indeholdt i indre værdi er den 22. februar 2021.Den første handelsdag med investeringsbeviser ekskl. udbytter indeholdt i indre værdi er den 23. februar 2021.Der gøres opmærksom på, at de endelige a conto udbytter for 2020 skal godkendes af bestyrelsen i fondens administrationsselskab den 26. marts 2021.De optjente udbytter for 2020 er vist i nedenstående tabel. Udbyttet er opgjort i kr. pr. investeringsbevis.Henvendelser vedrørende nærværende fondsbørsmeddelelse kan rettes til Seniorspecialist Helle Skovgaard,tlf.nr....

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.